Health
Tiny antibody component shows high potency in SARS-CoV-2 animal models – News-Medical.Net
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug–known as Ab8–for potential use as a therapeutic and prophylactic against SARS-CoV-2.
The researchers report today in the journal…
-
Noosa News22 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News23 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business16 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General21 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands